Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20558343 | 0.89 | KMT2A (0.36) | L3MBTL1CYP1A2CYP3A4CYP2D6CYP2C19 | |
| SCHEMBL16915398 | 0.88 | L3MBTL1 (0.34) | L3MBTL1CYP1A2CYP3A4CYP2D6CYP2C19 | |
| SCHEMBL31532186 | 0.88 | L3MBTL1 (0.34) | L3MBTL1CYP1A2CYP3A4CYP2D6CYP2C19 | |
| SCHEMBL20558547 | 0.83 | POLB (0.33) | L3MBTL1CYP1A2CYP3A4CYP2D6CYP2C19 | |
| SCHEMBL31403297 | 0.81 | CXCR1 (0.38) | L3MBTL1CYP1A2CYP3A4CYP2D6CYP2C19 | |
| SCHEMBL16915394 | 0.81 | CXCR1 (0.38) | L3MBTL1CYP1A2CYP3A4CYP2D6CYP2C19 | |
| SCHEMBL23795191 | 0.75 | HPGD (0.38) | L3MBTL1CYP1A2CYP3A4CYP2C19POLB | |
| SCHEMBL31149018 | 0.75 | HPGD (0.38) | L3MBTL1CYP1A2CYP3A4CYP2C19POLB | |
| SCHEMBL20607620 | 0.74 | POLB (0.33) | L3MBTL1CYP1A2CYP3A4CYP2D6CYP2C19 | |
| SCHEMBL29551202 | 0.74 | POLB (0.33) | L3MBTL1CYP1A2CYP3A4CYP2D6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3094631-B2 | PYRIMIDINYLOXY BENZENE DERIVATIVES AS HERBICIDES | FMC CORP (US) | 2024-12-25 | — | — | EP | claimed |
| CN-105916849-B | Pyrimidinyloxybenzene derivatives as herbicides | FMC公司 | 2020-07-07 | — | — | CN | claimed |
| US-10654840-B2 | Pyrimidinyloxy benzene derivatives as herbicides | FMC CORPORATION (US) | 2020-05-19 | — | — | US | claimed |
| EP-3094631-B1 | PYRIMIDINYLOXY BENZENE DERIVATIVES AS HERBICIDES | FMC CORP (US) | 2019-01-09 | — | — | EP | claimed |
| US-10131652-B2 | Pyrimidinyloxy benzene derivatives as herbicides | FMC CORPORATION | 2018-11-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10131652-B2 | Pyrimidinyloxy benzene derivatives as herbicides | DDT, NQO2, CBR3 | L3MBTL1 1415/4885CYP1A2 34/4885CYP3A4 111/4885 |
| US-10654840-B2 | Pyrimidinyloxy benzene derivatives as herbicides | DDT, NQO2, CBR3 | L3MBTL1 1415/4885CYP1A2 34/4885CYP3A4 111/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.